4526 — Riken Vitamin Co Balance Sheet
0.000.00%
- ¥84bn
- ¥75bn
- ¥96bn
- 71
- 68
- 78
- 87
Annual balance sheet for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 19,230 | 17,302 | 19,155 | 23,384 | 22,298 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18,311 | 18,715 | 20,116 | 23,114 | 21,808 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 53,326 | 52,790 | 58,126 | 66,521 | 65,699 |
| Net Property, Plant And Equipment | 27,861 | 25,428 | 23,637 | 23,382 | 25,525 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 106,535 | 102,660 | 105,223 | 118,776 | 112,999 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 52,812 | 18,221 | 18,924 | 31,117 | 21,129 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 60,378 | 36,140 | 33,878 | 42,163 | 33,836 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 46,157 | 66,520 | 71,345 | 76,613 | 79,163 |
| Total Liabilities & Shareholders' Equity | 106,535 | 102,660 | 105,223 | 118,776 | 112,999 |
| Total Common Shares Outstanding |